A NOVEL NONPEPTIDE HIV-1 PROTEASE INHIBITOR - ELUCIDATION OF THE BINDING MODE AND ITS APPLICATION IN THE DESIGN OF RELATED ANALOGS

被引：85

作者：

LUNNEY, EA ^{[1
]}

HAGEN, SE ^{[1
]}

DOMAGALA, JM ^{[1
]}

HUMBLET, C ^{[1
]}

KOSINSKI, J ^{[1
]}

TAIT, BD ^{[1
]}

WARMUS, JS ^{[1
]}

WILSON, M ^{[1
]}

FERGUSON, D ^{[1
]}

HUPE, D ^{[1
]}

TUMMINO, PJ ^{[1
]}

BALDWIN, ET ^{[1
]}

BHAT, TN ^{[1
]}

LIU, BS ^{[1
]}

ERICKSON, JW ^{[1
]}

机构：

[1] NCI,FREDERICK CANC RES & DEV CTR,PRI DYNCORP,STRUCT BIOCHEM PROGRAM,FREDERICK,MD 21702

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1994年 / 37卷 / 17期

关键词：

D O I：

10.1021/jm00043a006

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV-1 protease has been identified as a significant target enzyme in AIDS research. While numerous peptide-derived inhibitors have been described, the identification of a nonpeptide inhibitor remains an important goal. Using an HIV-1 protease mass screening technique, 4-hydroxy-3-(3-phenoxypropyl)-2H-1-benzopyran-2-one (1) was identified as a nonpeptide competitive inhibitor of the enzyme. Employing a Monte Carlo-based docking procedure, the coumarin was docked in the active site of the enzyme, revealing a binding mode that was later confirmed by the X-ray crystal analysis, Several analogs were prepared to test the binding interactions and improve the overall binding affinity. The most active compound in the study was 4,7-dihydroxy-3-[4-(2-methoxyphenyl)butyl]-2H-1-benzopyran-2-one (31).

引用

页码：2664 / 2677

页数：14

共 43 条

[11] AUTOMATED DOCKING OF SUBSTRATES TO PROTEINS BY SIMULATED ANNEALING [J].

GOODSELL, DS ;

OLSON, AJ .

PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1990, 8 (03) :195-202

[12]

GRAVES BJ, 1992, STRUCTURE FUNCTION A, P455

[13]

GUNTHER A, 1898, CHEM BER, V31, P2134

[14]

HERMODSON MA, 1971, J MED CHEM, V14, P167

[15] PENICILLIN DERIVED C2-SYMMETRICAL DIMERS AS NOVEL INHIBITORS OF HIV-1 PROTEINASE [J].

HUMBER, DC ;

CAMMACK, N ;

COATES, JAV ;

COBLEY, KN ;

ORR, DC ;

STORER, R ;

WEINGARTEN, GG ;

WEIR, MP .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (16) :3080-3081

[16]

JORDAN SP, 1992, J BIOL CHEM, V267, P20028

[17] PARTIAL INHIBITION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE RESULTS IN ABERRANT VIRUS ASSEMBLY AND THE FORMATION OF NONINFECTIOUS PARTICLES [J].

KAPLAN, AH ;

ZACK, JA ;

KNIGGE, M ;

PAUL, DA ;

KEMPF, DJ ;

NORBECK, DW ;

SWANSTROM, R .

JOURNAL OF VIROLOGY, 1993, 67 (07) :4050-4055

[18] SYNTHESES OF FLUORESCENT DYES .9. NEW 4-HYDROXYCOUMARINS, 4-HYDROXY-2-QUINOLONES, 2H,5H-PYRANO[3,2-C]BENZOPYRAN-2,5-DIONES AND 2H,5H-PYRANO[3,2-C]QUINOLINE-2,5-DIONES [J].

KNIERZINGER, A ;

WOLFBEIS, OS .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 1980, 17 (02) :225-229

[19] ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].

KOHL, NE ;

EMINI, EA ;

SCHLEIF, WA ;

DAVIS, LJ ;

HEIMBACH, JC ;

DIXON, RAF ;

SCOLNICK, EM ;

SIGAL, IS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690

[20] A GEOMETRIC APPROACH TO MACROMOLECULE-LIGAND INTERACTIONS [J].

KUNTZ, ID ;

BLANEY, JM ;

OATLEY, SJ ;

LANGRIDGE, R ;

FERRIN, TE .

JOURNAL OF MOLECULAR BIOLOGY, 1982, 161 (02) :269-288

← 1 2 3 4 5 →